Main content

    Institutional Biosafety Committee (IBC)

    California Pacific Medical Center Research Institute’s Institutional Biosafety Committee (IBC). The National Institutes of Health considers IBCs to be "the cornerstone of institutional oversight of recombinant DNA research". Committee members review any recombinant DNA studies to be carried out here and ensure they are conducted according to the NIH Guidelines.

    Please direct IBC questions, form requests, and completed forms to:
    Virginia Giblin
    475 Brannan Street, Suite 130
    San Francisco, CA 94107

    Submission and Meeting Dates

    The following table lists dates for submission of forms and materials for the monthly IBC meeting.

    Registration Form Deadline
    IBC Meeting Dates
    January 4 January 11
    February 1 February 8
    March 1 March 8
    April 5 April 12
    May 3 May 10
    June 7 June 14
    July 5 July 12
    August 2 August 9
    September 6 September 13
    October 4 October 11
    November 1 November 8
    December 6 December 13

    NIH Guidelines for Research Involving Recombinant DNA Molecules
    Download a free copy of Adobe Acrobat Reader Opens new window to read the PDF files.